If a dialogue is established upon receipt of a promotional email, is there a requirement to provide both prescribing information and an unsubscribe option with each email response?

  • 9

    Clause 9 - High Standards, Format, Suitability and Causing Offence, Sponsorship

    9.1 High standards must be maintained at all times.

    The special nature of medicines and the professional audience to which the material is directed require that the standards set for the promotion of medicines are higher than those which might be acceptable for general commodity advertising.

    It follows therefore that certain types, styles and methods of promotion, even where they might be acceptable for the promotion of products other than medicines, are unacceptable. These include:

    • the display of naked or partially naked people for the purpose of attracting attention to the material or the use of sexual imagery for that purpose
    • ‘teaser’ advertising whereby promotional material is intended to ‘tease’ the recipient by eliciting an interest in something which will be following or will be available at a later date without providing any actual information about it
    • the use of inappropriate language abbreviations or emoticons particularly in digital communications
    • the provision of private prescription forms preprinted with the name of a medicine.

    MOST RECENT CASES See all Applicable Code year

    9.2 All material and activities must recognise the special nature of medicines and the professional standing of the audience to which they are directed and must not be likely to cause offence.

    9.3 The name or photograph of a member of a health profession must not be used in any way that is contrary to the conventions of that profession.

    9.4 Promotional material must not imitate the devices, copy, slogans or general layout adopted by other companies in a way that is likely to mislead or confuse.

    9.5 Promotional material must not include any reference to the Commission on Human Medicines, the Medicines and Healthcare Products Regulatory Agency or the licensing authority, unless this is specifically required by the licensing authority.

    9.6 Reproductions of official documents must not be used for promotional purposes unless permission has been given in writing by the appropriate body.

    9.7 Extremes of format, size or cost of material must be avoided.

    Informational or educational materials must be inexpensive, directly relevant to the practice of medicine or pharmacy and directly beneficial to the care of patients.

    9.8 Postcards, other exposed mailings, envelopes or wrappers must not carry matter which might be regarded as advertising to the public, contrary to Clause 26.1.

    9.9 The telephone, text messages, email, telemessages, facsimile, automated calling systems and other electronic data communications must not be used for promotional purposes, except with the prior permission of the recipient.

    MOST RECENT CASES See all Applicable Code year

    9.10 Material relating to medicines and their uses, whether promotional or not, and information relating to human health or diseases which is sponsored by a pharmaceutical company must clearly indicate that it has been sponsored by that company.

    The only exception to this is market research material which need not reveal the name of the company involved but must state that it is sponsored by a pharmaceutical company.

     

Yes. The provision of prescribing information would depend on the content of the enquiry and the response. Where the prescribing information is required on the original email then reference to its availability at the bottom of the email chain and/or a hyperlink to that part of the email should be provided with each response in that email chain, irrespective of the content of the response. It might be better in certain circumstances to start a new standalone email. The requirement to unsubscribe is required on all promotional emails.